EVP Brian Travis Buys 1750 Eastman Chemical Shares at $68.34/Share on 2025-08-27.
PorAinvest
viernes, 29 de agosto de 2025, 4:09 pm ET1 min de lectura
EMN--
The purchase of 1750 shares by Smith brings his direct beneficial ownership to 16,732 shares. Additionally, Smith received 2,200 phantom stock units under the company's Executive Deferred Compensation Plan, valued at $68.18 per share. These phantom units are subject to plan terms, including limited acceleration and withdrawal provisions, and will be paid in cash after Smith's employment termination [2].
Eastman Chemical has faced challenges in recent months, with a decline in revenue growth and below-average profitability metrics. However, the insider purchases may suggest optimism among executives regarding the company's future prospects. Investors should consider this information as part of their overall analysis, but not as a primary determinant for investment decisions [1].
References:
[1] https://www.benzinga.com/insights/news/25/08/47416263/evp-of-eastman-chemical-makes-252k-buy
[2] https://www.stocktitan.net/sec-filings/EMN/form-4-eastman-chemical-company-insider-trading-activity-82ef0059e79b.html
Eastman Chemical Company [EMN] has disclosed that EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith has purchased 1750 shares at a price of $68.34 per share on August 27, 2025.
Eastman Chemical Company [EMN] has disclosed that EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith has purchased 1750 shares at a price of $68.34 per share on August 27, 2025. The transaction, reported in a Form 4 filing with the U.S. Securities and Exchange Commission, signifies a significant insider buy. This follows a trend of insider purchases at Eastman Chemical, indicating a positive outlook on the company's stock performance [1].The purchase of 1750 shares by Smith brings his direct beneficial ownership to 16,732 shares. Additionally, Smith received 2,200 phantom stock units under the company's Executive Deferred Compensation Plan, valued at $68.18 per share. These phantom units are subject to plan terms, including limited acceleration and withdrawal provisions, and will be paid in cash after Smith's employment termination [2].
Eastman Chemical has faced challenges in recent months, with a decline in revenue growth and below-average profitability metrics. However, the insider purchases may suggest optimism among executives regarding the company's future prospects. Investors should consider this information as part of their overall analysis, but not as a primary determinant for investment decisions [1].
References:
[1] https://www.benzinga.com/insights/news/25/08/47416263/evp-of-eastman-chemical-makes-252k-buy
[2] https://www.stocktitan.net/sec-filings/EMN/form-4-eastman-chemical-company-insider-trading-activity-82ef0059e79b.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios